Rate of Clinically Significant Postoperative Pancreatic Fistula in Pancreatic Neuroendocrine Tumors
- 24 April 2012
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 36 (7) , 1517-1526
- https://doi.org/10.1007/s00268-012-1598-9
Abstract
Background: In 2005, the International Study Group of Pancreatic Fistula (ISGPF) developed a definition and grading system for postoperative pancreatic fistula (POPF). The authors sought to determine the rate of POPF after enucleation and/or resection of pancreatic neuroendocrine tumors (PNET) and to identify clinical, surgical, or pathologic factors associated with POPF.Methods: A retrospective analysis of pancreatic enucleations and resections performed from March 1998 to April 2010. We defined a clinically significant POPF as a grade B that required nonoperative intervention and grade C.Results: One hundred twenty‐two patients were identified; 62 patients had enucleations and 60 patients had resections of PNET. The rate of clinically significant POPF was 23.7 % (29/122). For pancreatic enucleation, the POPF rate was 27.4 % (17/62, 14 grade B, 3 grade C). The pancreatic resection group had a POPF rate of 20 % (12/60, 10 grade B, 2 grade C). This difference was not significant (p = 0.4). In univariate analyses, patients in the enucleation group with hereditary syndromes (p = 0.02) and non‐insulinoma tumors (p = 0.02) had a higher POPF rate. Patients in the resection group with body mass index (BMI) > 25 (p < 0.01), multiple endocrine neoplasia type 1 (MEN‐1; p < 0.01) and those who underwent simultaneous multiple procedures (p = 0.02) had a higher POPF rate. Multivariate analyses revealed that hereditary syndromes were able to predict POPF in the enucleation group, while having BMI > 25 and increasing lesion size were also associated with POPF in the group undergoing resection.Conclusions: We found a clinically significant POPF rate after surgery in PNET to be 23.7 % with no difference by the type of operation. Our POPF rate is comparable to that reported in the literature for pancreatic resection for other types of tumors. Certain inherited genetic diseases—von Hippel–Lindau disease (VHL) and MEN‐1—were associated with higher POPF rates.Keywords
This publication has 41 references indexed in Scilit:
- Moving towards the New International Study Group for Pancreatic Surgery (ISGPS) definitions in pancreaticoduodenectomy: a comparison between the old and newHPB, 2011
- Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine TumorsJournal of Hematology & Oncology, 2011
- Analysis of Pancreatic Fistula According to the International Study Group on Pancreatic Fistula Classification Scheme for 294 Patients Who Underwent Pancreaticoduodenectomy in a Single CenterPancreas, 2011
- Pancreatic Neuroendocrine TumorsEndocrine Research, 2011
- Small Pancreatic and Periampullary Neuroendocrine Tumors: Resect or Enucleate?Journal of Gastrointestinal Surgery, 2009
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survivalAnnals of Oncology, 2008
- Clinical and Economic Validation of the International Study Group of Pancreatic Fistula (ISGPF) Classification SchemeAnnals of Surgery, 2007
- Assessment of Complications After Pancreatic SurgeryAnnals of Surgery, 2006
- Endocrine tumours of the pancreasPublished by Elsevier ,2005
- Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistulaJournal of Gastrointestinal Surgery, 2004